Study to Evaluate Effectiveness of Aranesp®
NCT00117130
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Kidney Disease
Interventions
DRUG:
Aranesp®
Sponsor
Amgen